GBC AG Initiates Coverage on Marinomed Biotech AG – Buy Recommendation with Price Target of EUR 42.00
|
EQS-News: GBC AG
/ Key word(s): Study/Forecast
GBC AG Initiates Coverage on Marinomed Biotech AG – Buy Recommendation with Price Target of EUR 42.00
The pipeline is further complemented by Solv4U, a platform through which external pharmaceutical companies can access Marinosolv technology for their own drug development.
According to our analysts, Marinomed’s formulations address not only medical needs but also regulatory and patient demands, such as rapid efficacy, preservative-free solutions, and convenient administration – positioning the company as a relevant solution provider for potential global licensing partners.
27.03.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
2107492 27.03.2025 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.